Home Cart Sign in  
Chemical Structure| 936890-98-1 Chemical Structure| 936890-98-1

Structure of OSI-027
CAS No.: 936890-98-1

Chemical Structure| 936890-98-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

OSI-027 (ASP7486) is a potent, selective, orally active, and ATP-competitive mTOR kinase inhibitor with an IC50 of 4 nM. It targets both mTORC1 and mTORC2 with IC50s of 22 nM and 65 nM, respectively.

Synonyms: ASP7486; CERC 006; AEVI-006

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of OSI-027

CAS No. :936890-98-1
Formula : C21H22N6O3
M.W : 406.44
SMILES Code : O=C([C@H]1CC[C@H](C2=NC(C(N3)=CC4=C3C(OC)=CC=C4)=C5C(N)=NC=NN52)CC1)O
Synonyms :
ASP7486; CERC 006; AEVI-006
MDL No. :MFCD20275101
InChI Key :JROFGZPOBKIAEW-UHFFFAOYSA-N
Pubchem ID :135398516

Safety of OSI-027

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of OSI-027

PI3K-AKT

Isoform Comparison

Biological Activity

Target
  • mTORC1

    mTORC1, IC50:22 nM

  • mTORC2

    mTORC2, IC50:65 nM

  • mTOR

    mTOR, IC50:4 nM

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00698243 Any Solid Tumor or Lymphoma PHASE1 COMPLETED 2025-02-13 Karmanos Cancer Institute, Det... More >>roit, Michigan, 48201, United States|University Hospitals Leuven, Leuven, 3000, Belgium|Royal Mardsen Hospital, Sutton, Surrey, SM2 5PT, United Kingdom Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.46mL

0.49mL

0.25mL

12.30mL

2.46mL

1.23mL

24.60mL

4.92mL

2.46mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories